REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bio-Fd&C Co.,Ltd. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Bio-Fd&C Co.,Ltd. Profile Updated: July 04, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Bio-Fd&C Co.,Ltd. is engaged in manufacturing of medicinal chemicals, antibiotics and biological products. The company offers products such as Various peptides, Phytopeptides, Anti-aging peptides, Anti-wrinkle peptides, Whitening peptides, Anti-inflammatory peptides, Anti-oxidant peptides, Anti-microbial peptides and other related products. Bio-Fd&C Co.,Ltd. was incorporated in 2005 and is based in Incheon, South Korea.

Headquarters
30, Songdomirae-ro Yeonsu-gu Incheon
Incheon; Incheon;

Contact Details: Purchase the Bio-Fd&C Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Incorporation Date:
November 11, 2005
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Company Performance
Financial values in the chart are available after Bio-Fd&C Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
32.43%▲
Total operating revenue
32.43%▲
Operating profit (EBIT)
55.56%▲
EBITDA
57.55%▲
Net Profit (Loss) for the Period
49.1%▲
Total assets
156.23%▲
Total equity
233.55%▲
Operating Profit Margin (ROS)
4.57%▲
Net Profit Margin
3.05%▲
Return on Equity (ROE)
-10.13%▼
Debt to Equity Ratio
-4.85%▼
Quick Ratio
6.06%▲
Cash Ratio
1.17%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo